Article Information
History
- February 22, 2022.
Article Versions
- Version 1 (February 3, 2022 - 11:45).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Raja Dhar1,*,
- John Kirkpatrick2,*,
- Laura Gilbert3,
- Arjun Khanna4,
- Mahavir Madhavdas Modi5,
- Rakesh K. Chawla6,
- Sonia Dalal7,
- Venkata Nagarjuna Maturu8,
- Marcel Stern9,
- Oliver Keppler9,
- Ratko Djukanović10,# and
- Stephan Gadola10,11,#,†
- 1Department of Pulmonology, CMRI Hospital, Kolkata, India
- 2John Kirkpatrick, MSc, Independent Researcher, Cambridgeshire, UK
- 3Laura Gilbert, Rutherford Research, Hampshire, UK
- 4Pulmonary and Critical care medicine, Yashoda Superspeciality Hospital, Kaushambi, Ghaziabad, UP, India
- 5Ruby Hall Clinic, Pune, Maharashtra, India
- 6Saroj Super Speciality Hospital and Jaipur Golden Hospital, Dept of Respiratory Medicine, Critical Care and Sleep Disorders, New Delhi, India
- 7Sterling Hospital and Kalyan Hospital, Vadodara, India
- 8Yashoda Hospitals, Hyderabad, India
- 9Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany
- 10Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, and NIHR Southampton Biomedical Research Centre, Southampton, UK
- 11Rheumatology and Pain Medicine, Bethesda Hospital, Basel, Switzerland
- ↵†Corresponding Author: Professor Stephan Gadola, MD, PhD, FRCP, Address: Bethesda Hospital, Gellertstrasse 144, CH-4052 Basel, Switzerland, Email : Stephan.Gadola{at}bethesda-spital.ch, Telephone : +41 (0)61 315 23 29
Posted February 22, 2022.
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)
